marketinsider

Unveiling the Numbers: A Recap of Shutterstock Inc.’s Q3 2024 Earnings Call

Shutterstock Q3 2024 Earnings Conference Call Highlights Key Speakers: Rik Powell – Senior Vice President, Finance and IR Paul Hennessy – Chief Executive Officer Jarrod Yahes – Chief Financial Officer Conference Call Participants: Curt Nagle – Bank of America Youssef Squali – Truist Securities Bernie McTernan – Needham & Company Matthew Cost – MS Andrew…

Read More

Innovative and Articulate: Protagenic Therapeutics Announces Pricing of Private Placement for $12.75 Million

Protagenic Therapeutics Announces Purchase Agreement for 1,948,295 Shares of Common Stock New York, NY / ACCESSWIRE / October 29, 2024 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) Biopharmaceutical Innovation Protagenic Therapeutics, a leader in biopharmaceutical innovation, has recently made a significant announcement regarding a purchase agreement for the sale of an aggregate of 1,948,295 shares of common…

Read More

Mark your calendars! Electromed Inc. to Unveil First Quarter Fiscal 2025 Financial Results on November 12, 2024 at 5:00 PM ET

Exciting News from Electromed, Inc. Get Ready for the Big Announcement! Hey there, readers! Do we have some exciting news for you today! Electromed, Inc., a leading provider of innovative airway clearance technologies, has just announced that they will be releasing their financial results for the fiscal 2025 first quarter on November 12, 2024. If…

Read More

Mark your calendars! BrainsWay’s Third Quarter 2024 Financial Results are coming on November 12, 2024 – get ready to geek out with us!

Welcome to the latest news in mental health technology! Exciting Updates from BrainsWay Ltd. BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter…

Read More

Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart in Type 1 Diabetes Patients Undergoing Islet Transplantation

Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart Breakthrough in Type 1 Diabetes Patients Undergoing Islet Transplantation Diabetes has been a prevalent health issue affecting millions of people worldwide, with Type 1 Diabetes (T1D) being a particularly challenging condition to manage. However, a recent development by Eledon Pharmaceuticals has sparked hope and excitement…

Read More

Shutterstock’s Third Quarter 2024 Financial Results: A Reflection of Success and Growth

Shutterstock’s Third Quarter 2024 Financial Results: A Reflection of Success and Growth New York, Oct. 29, 2024 Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform offering high-quality creative content for transformative brands, digital media, and marketing companies, has announced its financial results for the third quarter ended September 30, 2024. Paul Hennessy, the Company’s…

Read More